Zunica, Elizabeth R. M.
Axelrod, Christopher L.
Cho, Eunhan
Spielmann, Guillaume
Davuluri, Gangarao
Alexopoulos, Stephanie J.
Beretta, Martina
Hoehn, Kyle L.
Dantas, Wagner S.
Stadler, Krisztian
King, William T.
Pergola, Kathryn
Irving, Brian A.
Langohr, Ingeborg M.
Yang, Shengping
Hoppel, Charles L.
Gilmore, L. Anne
Kirwan, John P. https://orcid.org/0000-0001-7321-9917
Funding for this research was provided by:
National Institute of General Medical Sciences (U54GM104940, 5P30GM118430, P20GM135002)
National Center for Advancing Translational Sciences (KL2TR003097)
National Health and Medical Research Council (GNT1163903)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK072476)
Article History
Received: 24 February 2021
Accepted: 22 September 2021
First Online: 9 October 2021
Declarations
:
: All experiments and procedures involving animals were approved by the Institutional Animal Care and Use Committee of the Pennington Biomedical Research Center (permit number 1052).
: All authors give consent for publication of the manuscript.
: K.L.H. is an equity holder in Life Biosciences, a company that has commercial interest in mitochondrial uncouplers as therapeutics. All other authors declare no competing financial interests.